Indirect and mixed treatment comparisons in arthritis research
Open Access
- 21 August 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (suppl 4) , iv5-iv9
Abstract
Evidence for the efficacy of biologic therapies in inflammatory arthritis comes overwhelmingly from placebo-controlled trials. Increasingly, however, authorities responsible for purchasing and re-imbursement have tried to determine whether there are differences between these powerful new therapies, which would lead them to recommend some in preference to others, either on grounds of efficacy or cost-effectiveness. In the absence of head-to-head trial comparisons, indirect comparisons may be used. Furthermore, network meta-analysis, also known as mixed treatment comparisons can combine information from trials in a connected network. These methods allow inferences about head-to-head comparisons even when there is little or no head-to-head evidence, which has caused some concern. In this article we briefly review these methodologies and describe results from recent applications to inflammatory arthritis in the clinical literature. We then focus on how the methodologies are used in decision making, taking as an illustration some recent technology appraisals conducted by the National Institute for Health and Clinical Excellence in the UK. We conclude that, in practice, the key decisions have been based on results from placebo-controlled trials.Keywords
This publication has 15 references indexed in Scilit:
- A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overviewCanadian Medical Association Journal, 2009
- Use of Indirect and Mixed Treatment Comparisons for Technology AssessmentPharmacoEconomics, 2008
- The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisonsRheumatology, 2007
- Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritisStatistics in Medicine, 2006
- Assessing Evidence Inconsistency in Mixed Treatment ComparisonsJournal of the American Statistical Association, 2006
- Simultaneous comparison of multiple treatments: combining direct and indirect evidenceBMJ, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Carrier Screening for Cystic FibrosisMedical Decision Making, 1998